Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism RIPK3 inhibitors(receptor interacting serine/threonine kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza A virus infection | Preclinical | US | 01 Apr 2024 | |
Influenza A virus infection | Preclinical | US | 01 Apr 2024 | |
Influenza A virus infection | Preclinical | US | 01 Apr 2024 |